Supplementation of branched-chain amino acids decreases fat accumulation in the liver through intestinal microbiota-mediated production of acetic acid | Scientific Reports
Supplementation of branched-chain amino acids decreases fat accumulation in the liver through intestinal microbiota-mediated production of acetic acid | Scientific Reports
EAA vs BCAA: What You Need To Know | Fatty Liver Disease
Diabetes Researchers Find Switch for Fatty Liver Disease | Duke Today
Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy - ScienceDirect
Comparison of liver, muscle and fat in BCAA metabolism and the effect... | Download Scientific Diagram
Biomedicines | Free Full-Text | The Emerging Role of Branched-Chain Amino Acids in Liver Diseases
Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy - ScienceDirect
The Emerging Role of Branched-Chain Amino Acids inLiver Diseases
IJMS | Free Full-Text | The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain α-Keto Acid Dehydrogenase (BCKD), in Human Pathophysiology
Malnutrition and liver disease in a developing country
How Amino Acids Benefit Liver Health: What You Should Know – The Amino Company
How Amino Acids Benefit Liver Health: What You Should Know – The Amino Company
JCM | Free Full-Text | MicroRNA Expression Relating to Dietary-Induced Liver Steatosis and NASH | HTML
JCI - Mitochondrial role in the neonatal predisposition to developing nonalcoholic fatty liver disease
Dietary protein insufficiency: an important consideration in fatty liver disease? | British Journal of Nutrition | Cambridge Core
Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction | JACC: Basic to Translational Science
Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease
Microbial metabolites in non-alcoholic fatty liver disease
Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation | Scientific Reports